{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-002189","form_type":"8-K","ticker":"KURA","cik":"0001422143","company_name":"Kura Oncology, Inc.","filed_at":"2025-01-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.591289+00:00","generated_at":"2026-05-28T10:13:20.266552+00:00","sec_items":["5.02","8.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Kura Oncology CMO Stephen Dale resigns; Mollie Leoni named CMO, Francis Burrows CSO","bullets":["Stephen Dale, M.D. resigned as CMO effective Jan 2, 2025 due to personal health challenges.","Settlement provides 18 months base salary, 2024 bonus, and extended option exercise through Mar 31, 2026.","Mollie Leoni, M.D. appointed Chief Medical Officer on Jan 2, 2025.","Francis Burrows, Ph.D. appointed Chief Scientific Officer on Jan 2, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-002189","json":"https://secwatch.observer/filing/0001193125-25-002189.json","markdown":"https://secwatch.observer/filing/0001193125-25-002189.md","text":"https://secwatch.observer/filing/0001193125-25-002189.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525002189/0001193125-25-002189-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525002189/d912671d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T10:13:20.266552+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a5788f6815","claim":"Stephen Dale resigned as Chief Medical Officer at Kura Oncology, Inc..","evidence_excerpt":"On January 1, 2025 (the “Dale Separation Date”), Stephen Dale, M.D. tendered his resignation from his position as the Chief Medical Officer of Kura Oncology, Inc. (the “Company”), effective as of January 2, 2025, in order to focus on recovery from personal health challenges.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525002189/0001193125-25-002189-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}